These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 10338273

  • 21. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo.
    Johansson M, Friedemann M, Hoffer B, Strömberg I.
    Exp Neurol; 1995 Jul; 134(1):25-34. PubMed ID: 7672036
    [Abstract] [Full Text] [Related]

  • 22. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C, Kirik D, Björklund A.
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [Abstract] [Full Text] [Related]

  • 23. Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.
    Espejo M, Cutillas B, Arenas TE, Ambrosio S.
    Cell Transplant; 2000 Feb; 9(1):45-53. PubMed ID: 10784066
    [Abstract] [Full Text] [Related]

  • 24. Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor.
    Ding YM, Jaumotte JD, Signore AP, Zigmond MJ.
    J Neurochem; 2004 May; 89(3):776-87. PubMed ID: 15086533
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson disease: long-term storage.
    Hebb AO, Hebb K, Ramachandran AC, Mendez I.
    J Neurosurg; 2003 May; 98(5):1078-83. PubMed ID: 12744369
    [Abstract] [Full Text] [Related]

  • 33. Improved survival of embryonic porcine dopaminergic neurons in coculture with a conditionally immortalized GDNF-producing hippocampal cell line.
    Meyer M, Johansen J, Gramsbergen JB, Johansen TE, Zimmer J.
    Exp Neurol; 2000 Jul; 164(1):82-93. PubMed ID: 10877918
    [Abstract] [Full Text] [Related]

  • 34. Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo.
    Strömberg I, Björklund L, Johansson M, Tomac A, Collins F, Olson L, Hoffer B, Humpel C.
    Exp Neurol; 1993 Dec; 124(2):401-12. PubMed ID: 7904571
    [Abstract] [Full Text] [Related]

  • 35. Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons.
    Potter ED, Ling ZD, Carvey PM.
    Cell Tissue Res; 1999 May; 296(2):235-46. PubMed ID: 10382268
    [Abstract] [Full Text] [Related]

  • 36. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons.
    Engele J.
    J Neurosci Res; 1998 Aug 15; 53(4):405-14. PubMed ID: 9710260
    [Abstract] [Full Text] [Related]

  • 37. Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.
    Petersen A, Hansson O, Emgård M, Brundin P.
    Cell Transplant; 2000 Aug 15; 9(5):577-84. PubMed ID: 11144955
    [Abstract] [Full Text] [Related]

  • 38. Minor immunoreactivity in GDNF-, BDNF-, or NT-3-treated substantia nigra allografts.
    Shinoda M, Hoffer BJ, Olson L.
    J Neural Transplant Plast; 1997 Aug 15; 6(2):83-96. PubMed ID: 9306240
    [Abstract] [Full Text] [Related]

  • 39. Effect of glial cell line-derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies.
    Chaturvedi RK, Agrawal AK, Seth K, Shukla S, Chauhan S, Shukla Y, Sinha C, Seth PK.
    Int J Dev Neurosci; 2003 Nov 15; 21(7):391-400. PubMed ID: 14599485
    [Abstract] [Full Text] [Related]

  • 40. Relative sparing of calretinin containing neurons in the substantia nigra of 6-OHDA treated rat parkinsonian model.
    Kim BG, Shin DH, Jeon GS, Seo JH, Kim YW, Jeon BS, Cho SS.
    Brain Res; 2000 Feb 07; 855(1):162-5. PubMed ID: 10650144
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.